Dr. Reddy’s introduces Pfizer drug copy to deal with OAB

Toviaz model had U.S. gross sales of roughly $211 million MAT

Toviaz model had U.S. gross sales of roughly $211 million MAT

Pharma main Dr. Reddy’s Laboratories has launched Fesoterodine Fumarate Prolonged-Launch Tablets, a therapeutic generic equal to Pfizer’s Toviaz (fesoterodine fumarate) ER Tablets, within the U.S.

Indicated for remedy of overactive bladder (OAB) in adults with signs of urge urinary incontinence, urgency, and frequency, the product has been launched by the corporate following U.S. Meals and Drug Administration (USFDA) approval.

The Toviaz model had U.S. gross sales of roughly $211 million MAT for the newest 12 months ending Could 2022, Dr. Reddy’s mentioned citing IQVIA numbers. The Fesoterodine Fumarate Prolonged-Launch Tablets can be found in 4 mg and eight mg Tablets, every in bottle depend sizes of 30, the corporate mentioned in a launch on Friday.

By- The Hindu

from Tadka News https://ift.tt/h1e5PRj
via NEW MOVIE DOWNLOAD